Your browser doesn't support javascript.
loading
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.
McCune, Jeannine S; Wang, Tao; Bo-Subait, Khalid; Aljurf, Mahmoud; Beitinjaneh, Amer; Bubalo, Joseph; Cahn, Jean-Yves; Cerny, Jan; Chhabra, Saurabh; Cumpston, Aaron; Dupuis, L Lee; Lazarus, Hillard M; Marks, David I; Maziarz, Richard T; Norkin, Maxim; Prestidge, Tim; Mineishi, Shin; Krem, Maxwell M; Pasquini, Marcelo; Martin, Paul J.
Afiliação
  • McCune JS; Clinical Research Division, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, WA, USA; Department of Population Sciences, City of Hope, Duarte, CA, USA. Electronic address: jmccune@coh.org.
  • Wang T; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Bo-Subait K; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Aljurf M; Adult HSCT Program, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Beitinjaneh A; Department of Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL, USA.
  • Bubalo J; Department of Medicine, Oregon Health and Science University Hospital, Portland, OR, USA.
  • Cahn JY; Department of Medicine, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
  • Cerny J; Department of Medicine, University of Massachusetts Memorial Medical Center, Worcester, MA, USA.
  • Chhabra S; Department of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI.
  • Cumpston A; Division of Oncology, West Virginia University Hospitals, Morgantown, WV, USA.
  • Dupuis LL; The Hospital for Sick Children and Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
  • Lazarus HM; Department of Medicine, Case Western Reserve University, Cleveland, OH, USA.
  • Marks DI; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Maziarz RT; Department of Medicine, Oregon Health and Science University Hospital, Portland, OR, USA.
  • Norkin M; Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
  • Prestidge T; Blood and Cancer Centre, Starship Child Health, Central Auckland, New Zealand.
  • Mineishi S; Department of Medicine, Penn State Hershey Medical Center, Hershey, PA, USA.
  • Krem MM; Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, KY, USA.
  • Pasquini M; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Martin PJ; Clinical Research Division, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, WA, USA.
Biol Blood Marrow Transplant ; 25(7): 1424-1431, 2019 07.
Article em En | MEDLINE | ID: mdl-30871976

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenitoína / Convulsões / Bussulfano / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Ciclofosfamida / Anticonvulsivantes Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenitoína / Convulsões / Bussulfano / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Ciclofosfamida / Anticonvulsivantes Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article